Immediate Impact

73 standout
Sub-graph 1 of 22

Citing Papers

Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Standout
Age-Related Macular Degeneration
2024 Standout
1 intermediate paper

Works of Derrick Kaufman being referenced

Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
2021
Observation on Renal Outcomes in the Veterans Affairs Diabetes Trial
2011

Author Peers

Author Last Decade Papers Cites
Derrick Kaufman 99 120 71 96 9 402
Rachel Gorodkin 30 29 31 27 15 395
Gordon S. Crabtree 43 71 85 25 11 369
E. Thibout 53 28 28 30 13 415
Selahattin Aydın 81 17 50 31 9 413
James Berkman 79 22 96 23 11 347
L McGuigan 158 107 5 93 11 415
Nina George 122 154 11 13 10 356
Richard S. Bornstein 29 60 13 25 11 376
S. T. Knudsen 54 18 47 19 9 350
D. Salomon 150 11 17 19 15 429

All Works

Loading papers...

Rankless by CCL
2026